Cosmo announces that Acacia Pharma Group plc obtains U.S. FDA Approval of BARHEMSYS®
Cosmo Pharmaceuticals N.V. (“Cosmo”) announced today that Acacia Pharma Group plc (EURONEXT: ACPH) (“Acacia”) has obtained U.S. FDA approval for BARHEMSYS® for the prevention and treatment of PONV (post-operative nausea and vomiting) in adult patients.